| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10818073 | Clinical Biochemistry | 2005 | 5 Pages |
Abstract
Our findings demonstrate that a large percentage of patients with hypertriglyceridemia or impaired glucose tolerance, treated with lipid lowering agents, reach the LDL-cholesterol but not the apo B treatment targets.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Helena Vaverkova, Jiri Frohlich, Dagmar Jackuliakova, Dalibor Novotny,